<DOC>
	<DOCNO>NCT01229917</DOCNO>
	<brief_summary>The purpose study evaluate symptom impact probiotic Lactobacillus rhamnosus GG rhinovirus infection .</brief_summary>
	<brief_title>Rhinovirus Study With Lactobacillus Rhamnosus GG</brief_title>
	<detailed_description />
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>1 . Male female general good health ( stabilize chronic illness regular medication accept , otherwise mention exclusion criterion ) 2 . Age 1865 year 3 . Serum neutralize antibody titer 1:4 less challenge rhinovirus 4 . No clinically significant find prestudy nasal examination 5 . Females must negative urine pregnancy test , woman childbearing potential must use effective method birth control , limited birth control pill , contraceptive foam , diaphragm , IUD , surgical sterilization , abstinence , condoms 6 . Written informed consent must obtain enrollment study 1 . Suffer history significant allergic rhinitis time study 2 . Bronchial asthma lower respiratory tract disease , chronic obstructive lung disease emphysema 3 . Nasal abnormalities nasal pathology , irreversible nasal mucosal hypertrophy severe nasal septum derivation 4 . Pregnancy lactation 5 . History alcohol abuse ( regularly consumes 5 alcohol drink per day ) and/or drug abuse 12 month period immediately precede study enrollment 6 . Daily smoking within past 2 year 7 . Use investigational product participation device trial 30 day period immediately precede study enrollment 8 . Previous participation experimental study rhinovirus 39 9 . Allergy ingredient study product 10 . Have , determine investigator and/or sponsor 's medical monitor , surgical medical condition take medication dietary supplement could interfere interpretation study result jeopardize safety subject</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>